6 results
diagnosis anticoagulation cancer vte anemia aplastic differential platelets rheumatology sjogrens sweet thrombocytosis
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis. Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
►
 Treatment algorithm for VTE in Malignancy (A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... for VTE in Malignancy ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
Approach to Thrombocytosis - Elevated Platelet Count - Differential Diagnosis Algorithm Peripheral Smear concerning for malignancy?
→ Refer to hematology ... Rebound effect from treatment ... Rheumatologic, Vasculitides ... • Reaction to Medications ... #hematology
Sweet Syndrome Acute febrile neutrophilic dermatosis (Sweets Syndrome) is a skin condition characterized by fever and inflamed
Causes: - Idiopathic ... , breast CA - Hematologic ... Treatment: - Systemic ... #diagnosis #dermatology ... #oncology
Aplastic Anemia - Overview Who? • M = F • 3 peaks: 1) Childhood 2) 15-25 years 3) >60 years What? • Aplastic anemia
and petechiae Causes ... - Antithyroid medications ... Aplastic #Anemia #oncology ... #hematology #diagnosis ... #management
Sjogren's Syndrome Overview Epidemiology: • F > M: 9:1 • 5-6th Decades (can be any age) Autoimmune exocrinopathy multisystemic disease
Hypocomplementemia • Can cause ... and Arthritis Malignancy ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Diagnosis #Management
No results found for "Management algorithm treatment causes hematology vasculitis dermatology pharmacology medications oncology 2016 malignancy syndrome doac"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Management #algorithm #treatment #causes #hematology #vasculitis #dermatology #pharmacology #medications #oncology #2016 #malignancy #syndrome #doac